Literature DB >> 21073339

Pathogenesis of liver fibrosis.

Virginia Hernandez-Gea1, Scott L Friedman.   

Abstract

Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate cell activation represents a critical event in fibrosis because these cells become the primary source of extracellular matrix in liver upon injury. Use of cell-culture and animal models has expanded our understanding of the mechanisms underlying stellate cell activation and has shed new light on genetic regulation, the contribution of immune signaling, and the potential reversibility of the disease. As pathways of fibrogenesis are increasingly clarified, the key challenge will be translating new advances into the development of antifibrotic therapies for patients with chronic liver disease.

Entities:  

Mesh:

Year:  2011        PMID: 21073339     DOI: 10.1146/annurev-pathol-011110-130246

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  557 in total

Review 1.  ECM roles in the function of metabolic tissues.

Authors:  Guorui Huang; Daniel S Greenspan
Journal:  Trends Endocrinol Metab       Date:  2011-11-08       Impact factor: 12.015

2.  Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.

Authors:  Jeffrey C Horowitz; Iyabode O Ajayi; Priya Kulasekaran; David S Rogers; Joshua B White; Sarah K Townsend; Eric S White; Richard S Nho; Peter D R Higgins; Steven K Huang; Thomas H Sisson
Journal:  Int J Biochem Cell Biol       Date:  2011-10-25       Impact factor: 5.085

3.  Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells.

Authors:  Lei Chen; Yong-Ze Guo; Ai-di Li; Jun-Ji Ma; Hui-Yao Hao; Di Zhang; Yan Wang; Chen-Guang Ji; Wei Qi; Jia Wang; Hui-Qing Jiang
Journal:  Dig Dis Sci       Date:  2016-02-15       Impact factor: 3.199

4.  Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.

Authors:  Michel Fausther; Elise G Lavoie; Jonathan A Dranoff
Journal:  Curr Pathobiol Rep       Date:  2013-09

5.  Effects of Ganfukang on expression of connective tissue growth factor and focal adhesion kinase/protein kinase B signal pathway in hepatic fibrosis rats.

Authors:  Kun Zhang; Miao-na Jiang; Cai-hua Zhang; Cong Li; Yu-jie Jia
Journal:  Chin J Integr Med       Date:  2013-08-29       Impact factor: 1.978

6.  Comparison of diagnostic accuracies of two- and three-dimensional MR elastography of the liver.

Authors:  Hiroyuki Morisaka; Utaroh Motosugi; Kevin J Glaser; Shintaro Ichikawa; Richard L Ehman; Katsuhiro Sano; Tomoaki Ichikawa; Hiroshi Onishi
Journal:  J Magn Reson Imaging       Date:  2016-09-23       Impact factor: 4.813

7.  Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats.

Authors:  Chittapon Jantararussamee; Siripa Rodniem; Malai Taweechotipatr; Udomsri Showpittapornchai; Wisuit Pradidarcheep
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

8.  Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy.

Authors:  Hong-Min Ni; Benjamin L Woolbright; Jessica Williams; Bryan Copple; Wei Cui; James P Luyendyk; Hartmut Jaeschke; Wen-Xing Ding
Journal:  J Hepatol       Date:  2014-05-09       Impact factor: 25.083

9.  Diallyl trisulfide attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic oxidative stress in rats.

Authors:  Xiaojing Zhu; Feng Zhang; Liang Zhou; Desong Kong; Li Chen; Yin Lu; Shizhong Zheng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-02-21       Impact factor: 3.000

Review 10.  Regulation of wound healing and organ fibrosis by toll-like receptors.

Authors:  Peter Huebener; Robert F Schwabe
Journal:  Biochim Biophys Acta       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.